Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Redox proteomics of PANC-1 cells reveals the significance of HIF-1 signaling protein oxidation in pancreatic ductal adenocarcinoma pathogenesis. | J Transl Med | 2024 | 38493183 | PubTator, text mining | PubMed |
| Lactiplantibacillus plantarum K8 lysates regulate hypoxia-induced gene expression. | Sci Rep | 2024 | 38491188 | PubTator, text mining | PubMed |
| Novel furan chalcone modulates PHD-2 induction to impart antineoplastic effect in mammary gland carcinoma. | J Biochem Mol Toxicol | 2024 | 38486411 | PubTator, text mining | PubMed |
| Coexistence of Multiple Gene Variants in Some Patients with Erythrocytoses. | Mediterr J Hematol Infect Dis | 2024 | 38468832 | PubTator, text mining | PubMed |
| Guiding the HBO1 complex function through the JADE subunit. | Nat Struct Mol Biol | 2024 | 38448574 | PubTator, text mining | PubMed |
| Rapid evaluation of PHD2 inhibitory activity of natural products based on capillary electrophoresis online stacking strategy. | J Chromatogr B Analyt Technol Biomed Life Sci | 2024 | 38430605 | PubTator, text mining | PubMed |
| Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome. | Commun Biol | 2024 | 38418569 | PubTator, text mining | PubMed |
| Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma. | Cancer Med | 2024 | 38400673 | PubTator, text mining | PubMed |
| Identification of key genes of diabetic cardiomyopathy in hiPSCs-CMs based on bioinformatics analysis. | Mol Cell Biochem | 2024 | 38381273 | PubTator, text mining | PubMed |
| Interfacial Tissue Regeneration with Bone. | Curr Osteoporos Rep | 2024 | 38358401 | PubTator, text mining | PubMed |
| Correction: Association of the C allele of rs479200 in the EGLN1 gene with COVID-19 severity in Indian population: a novel finding. | Hum Genomics | 2024 | 38331989 | PubTator, text mining | PubMed |
| Prenatal alcohol exposure is associated with changes in placental gene co-expression networks. | Sci Rep | 2024 | 38302628 | PubTator, text mining | PubMed |
| Roles of exosomes in immunotherapy for solid cancers. | Cell Death Dis | 2024 | 38302430 | PubTator, text mining | PubMed |
| EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of Treatment. | Genet Test Mol Biomarkers | 2024 | 38294357 | PubTator, text mining | PubMed |
| Association of the C allele of rs479200 in the EGLN1 gene with COVID-19 severity in Indian population: a novel finding. | Hum Genomics | 2024 | 38291512 | PubTator, text mining | PubMed |
| A Case-Control Study of the Associations between EGLN1 Gene Polymorphisms and COPD. | Front Biosci (Landmark Ed) | 2024 | 38287821 | PubTator, text mining | PubMed |
| Case Report: A rare form of congenital erythrocytosis due to SLC30A10 biallelic variants-differential diagnosis and recommendation for biochemical and genetic screening. | Front Pediatr | 2024 | 38283630 | PubTator, text mining | PubMed |
| Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities. | Biomolecules | 2024 | 38275766 | PubTator, text mining | PubMed |
| Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. | Cell Death Discov | 2024 | 38267442 | PubTator, text mining | PubMed |
| A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic Keratoses. | J Pers Med | 2024 | 38248804 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=11